Loading...
Symbols:
Loading...
Symbols:
Myriad Genetics Inc. (MYGN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Myriad Genetics Inc. (MYGN)
45 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on MYGN
- Alan Brochstein(8)
- SA Editor Miriam Metzinger(7)
- Centient Biotech Investor(4)
- Zacks.com (3)
- Travis Johnson(3)
Most popular authors
(tracked in watchlists)
- SA Editor Eli Hoffmann(386)
- Andrew Wilkinson(333)
- SA Editor Judy Weil(185)
- Stockerblog (167)
- SA Editor Joan Wickham(145)
Most commented on authors
- Ketan Desai (28)
- Alan Brochstein(15)
- Stockerblog (7)
- Michael Cintolo(7)
- Mike Havrilla(5)
- Eight Areas to Consider About This Market
- Fast Money Recap - Will Goldman Be Tarnished? (11/10/08)
- Bullish Outlook for Preventive Medicine Companies Reflected in New ETF
- Tuesday's Trading Strategy
- Wall Street Breakfast: Must-Know News
- Myriad Genetics Spin-Off Would Be a Welcome Move
- Weekly Insider Buying/Selling Wrap and Economic Reports Preview
- Ten Ways to Invest in Utah
- Will Myriad Genetics Keep Its Momentum?
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Myriad Genetics: I Told You So
- Monday Options Update: C, MYGN, TSN, LLTC, F, GM, BEC, RNWK
- Myriad Genetics: Another Alzheimer's Compound Goes Down
- Bernanke, the Greatest Speculator - Fast Money (6/25/08)
- BioMarin, Myriad, and Regeneron Show a Quiet Strength
- In Tech We Trust - Fast Money Recap (6/20/08)
- Pfizer on a Respirator - Fast Money Recap (6/18/08)
- Will Wal-Mart Heat Up Chile? Fast Money (6/17/08)
- Friday Options Outlook (Update): SOLF, TIN, MYGN, MSFT, DNA, DRYS, HRS, DO, JCG, HHH
- Myriad Options on Alzheimers Disease
- Five Biotech Stocks to Weather a Down Market
- Fast Money Recap, 4/9/08: Airlines MayTake Off
- Fast Money Recap, 4/7/08: Is Energy Topping?
- Elan Corp. to Be a Blockbuster Biotech Company in 2008?
- Cancer Stocks Finish a Tough Quarter
- Why I've Decided that Now is the Time to Simplify My Portfolio
- Expect Pressure on Myriad Genetics Following Trial News
- Cancer Stocks: Tracking the Market
- Myriad Genetics: Exciting Alzheimer's Treatment In the Pipeline
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Myriad Genetics: Teeming With Opportunity
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Neurochem Announcement Lowers Alzhemed Expectations - Barron's
-
Biotech Day In Review: Regeneron Up On AMD Data
on Mar 28, 2007
- Biotech Stocks: InterMune Retrenches
-
Biotech Day In Review: InterMune Scaling Back Operations, MGI's Positive Trial
on Mar 21, 2007
- Biotech Day in Review: Hollis-Eden Loses Stockpile Contract for Neumune
- Biotech Day in Review: Lilly Buys Insomnia-Focused Hypnion
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »